{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:05:54Z","timestamp":1777439154623,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ahj.2012.05.008","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T12:45:58Z","timestamp":1342615558000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction"],"prefix":"10.1016","volume":"164","author":[{"given":"Michael D.","family":"Miedema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay N.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross F.","family":"Garberich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Knickelbine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2012.05.008_bb0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.05.008_bb0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.05.008_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2012.05.008_bb0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0025","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2012.05.008_bb0035","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0045","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.108.191092","article-title":"The American Heart Association's 2008 statement of principles for healthcare reform","volume":"118","author":"Gibbons","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.05.008_bb0050","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.05.008_bb0055","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.05.008_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2007.03.042","article-title":"Framingham risk score and prediction of coronary heart disease death in young men","volume":"154","author":"Berry","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2012.05.008_bb0065","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jacc.2003.11.061","article-title":"The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III","volume":"43","author":"Ford","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.05.008_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ahj.2005.01.059","article-title":"Design of a standardized system for transfer of patients with ST-elevation myocardial infarction for percutaneous coronary intervention","volume":"150","author":"Henry","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2012.05.008_bb0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.107.694141","article-title":"A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"116","author":"Henry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.05.008_bb0080","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0085","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.108.113357","article-title":"Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004","volume":"52","author":"Cutler","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2012.05.008_bb0090","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1345\/aph.1L181","article-title":"Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines","volume":"42","author":"Mann","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2012.05.008_bb0095","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1136\/bmj.282.6279.1847","article-title":"Strategy of prevention: lessons from cardiovascular disease","volume":"282","author":"Rose","year":"1981","journal-title":"Br Med J"},{"key":"10.1016\/j.ahj.2012.05.008_bb0100","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2005.07.052","article-title":"Detection of high-risk young adults and woman by coronary calcium and National Cholesterol Education Program Panel III guidelines","volume":"46","author":"Nasir","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.05.008_bb0105","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0735-1097(03)00187-6","article-title":"Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?","volume":"41","author":"Akosah","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.05.008_bb0110","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2009.1672","article-title":"Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006","volume":"302","author":"Kulina","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.05.008_bb0115","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.05.008_bb0120","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1001\/jama.2009.1685","article-title":"Simplifying the approach to the management of dyslipidemia","volume":"302","author":"Gaziano","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.05.008_bb0125","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.2009.1698","article-title":"Primary prevention of cardiovascular disease: time to get more or less personal?","volume":"302","author":"Hingorani","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.05.008_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCOUTCOMES.111.964676","article-title":"Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health","volume":"5","author":"Hayward","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2012.05.008_bb0135","unstructured":"Clinical guidelines and evidence review for lipid modification. National Collaborating Centre for Primary Care and Royal College of General Practioners. http:\/\/www.nice.org.uk\/nicemedia\/live\/11982\/40742\/40742\/.pdf. Last accessed July 11, 2011."},{"key":"10.1016\/j.ahj.2012.05.008_bb0140","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20142011 update: a guideline from the American Heart Association","volume":"123","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.05.008_bb0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archinternmed.2011.628","article-title":"Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials","volume":"172","author":"Seshasai","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","article-title":"Statin use and risk of diabetes mellitus in postmenopausal women in the women's health initiative","volume":"172","author":"Culver","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.05.008_bb0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","article-title":"Suboptimal statin adherence and discontinuation in primary and secondary prevention populations","volume":"19","author":"Ellis","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jacc.2008.02.085","article-title":"Time to foster a rational approach to preventing cardiovascular morbid events","volume":"52","author":"Cohn","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.05.008_bb0175","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.05.008_bb0180","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","article-title":"Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall Study","volume":"56","author":"Erbel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.05.008_bb0185","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/aje\/kwr120","article-title":"Association of small artery elasticity with incident cardiovascular disease in older adults: the Multi-Ethnic Study of Atherosclerosis","volume":"174","author":"Duprez","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2012.05.008_bb0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jash.2011.05.001","article-title":"Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations","volume":"5","author":"Duprez","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.ahj.2012.05.008_bb0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7326\/0003-4819-150-4-200902170-00005","article-title":"Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering","volume":"150","author":"Pletcher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2012.05.008_bb0200","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2012.05.008_bb0205","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(09)60611-5","article-title":"Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial","volume":"373","author":"Yusuf","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2012.05.008_bb0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(08)60418-3","article-title":"Laboratory-based versus non\u2013laboratory-based method for assessment of cardiovascular disease risk: the NHANES I follow-up study cohort","volume":"371","author":"Gaziano","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2012.05.008_bb0215","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-8703(03)00499-X","article-title":"Screening for early detection of cardiovascular disease in asymptomatic individuals","volume":"146","author":"Cohn","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2012.05.008_bb0220","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12265-008-9077-2","article-title":"The heart of New Ulm: a vision for the future","volume":"1","author":"Boucher","year":"2008","journal-title":"J Cardiovasc Transl Res"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031200364X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031200364X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:47:20Z","timestamp":1757569640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031200364X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S000287031200364X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2012.05.008","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2012.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}